Cabazitaxel: all 91 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate CancerNot yet recruitingNCT06890832Phase 2
- Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate CancerRecruitingNCT06738303Phase 2
- Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialRecruitingNCT06632977Phase 2
- Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)RecruitingNCT06085729Phase 1/2
- Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)RecruitingNCT05563558Phase 2
- Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical OutcomeNot yet recruitingNCT04622761Phase 2
- A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.CompletedNCT04495179Phase 2Results posted
- CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneCompletedNCT03934840Phase 2Results posted
- Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelActive, not recruitingNCT03419234Phase 2Results posted
- Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast CancerCompletedNCT03048942Phase 2Results posted
- A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)CompletedNCT02985957Phase 2Results posted
- Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)CompletedNCT02903160Phase 2Results posted
- Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT02844582Phase 2Results posted
- Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerActive, not recruitingNCT02522715Phase 1/2Results posted
- Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted AgentCompletedNCT02485691Phase 4Results posted
- Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or EnzalutamideTerminatedNCT02379390Phase 2Results posted
- Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate CancerCompletedNCT02218606Phase 2Results posted
- Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial MetastasesTerminatedNCT01934894Phase 2Results posted
- Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate CancerTerminatedNCT01845792Phase 2Results posted
- Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal AdenocarcinomaCompletedNCT01757171Phase 2Results posted
- Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System TumorsCompletedNCT01751308Phase 1/2Results posted
- Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT01718353Phase 2Results posted
- Cabazitaxel and Radiation For Patients With Prostate CancerTerminatedNCT01650285Phase 2Results posted
- Bristol Bladder TrialCompletedNCT01616875Phase 2Results posted
- Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung CancerCompletedNCT01500720Phase 2Results posted
- Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung CancerCompletedNCT01438307Phase 2Results posted
- Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based ChemotherapyCompletedNCT01437488Phase 2Results posted
- Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo RegimenTerminatedNCT01365130Phase 2Results posted
- Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate CancerTerminatedNCT01335204Phase 1/2Results posted
- Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerCompletedNCT01308580Phase 3Results posted
- Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT01308567Phase 3Results posted
- Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid TumorTerminatedNCT01001221Phase 1/2Results posted
- XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate CancerCompletedNCT00417079Phase 3Results posted
- Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT05340374Phase 1/2
- XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT05005728Phase 2
- A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate CancerActive, not recruitingNCT04709276Phase 2
- Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate CancerActive, not recruitingNCT04592237Phase 2
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Docetaxel Versus Cabazitaxel Post Abiraterone or EnzalutamideTerminatedNCT03764540Phase 2
- Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With DocetaxelCompletedNCT03295565Phase 2/3
- Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPCCompletedNCT03263650Phase 2
- Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy LinesStatus unknownNCT03257891Phase 2
- A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the PenisCompletedNCT03114254Phase 2
- Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)Status unknownNCT03050866Phase 2
- Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, ClarithromycinTerminatedNCT03043989Phase 1
- Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a DocetaxelCompletedNCT02961257Phase 3
- Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCsWithdrawnNCT02621190Phase 2
- Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.CompletedNCT02560337Phase 2
- Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)CompletedNCT02543255Phase 2
- Study of the Effect of Chemotherapy With Cabazitaxel on Prostate CancerCompletedNCT02512458Phase 2
- Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell CancerTerminatedNCT02478502Phase 2
- Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate CancerStatus unknownNCT02254785Phase 2
- Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard TreatmentTerminatedNCT02204332Phase 2
- A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)TerminatedNCT02166658Phase 2
- A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell TumorsCompletedNCT02115165Phase 2
- Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate CancerCompletedNCT02044354Phase 3
- Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With DocetaxelWithdrawnNCT02035124Phase 2
- The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen DeprivationWithdrawnNCT01981668Phase 1
- Efficacy Study Evaluating Chemotherapy in Prostate CancerStatus unknownNCT01978873Phase 3
- Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric CancerCompletedNCT01956149Phase 2
- A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of RelapseActive, not recruitingNCT01952223Phase 3
- Ph II Cabazitaxel DD LiposarcomaCompletedNCT01913652Phase 2
- Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLCWithdrawnNCT01913067Phase 2
- Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma MultiformeCompletedNCT01866449Phase 2
- Cabazitaxel in Relapsed and Metastatic NSCLCCompletedNCT01852578Phase 2
- Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)Status unknownNCT01830231Phase 2/3
- Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)CompletedNCT01779479Phase 2
- A Dose Finding Study of XRP6258 in Patients With Advanced Solid TumorsCompletedNCT01755390Phase 1
- Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate CancerWithdrawnNCT01750866Phase 2
- Cabazitaxel in Platinum Refractory Ovarian CancerTerminatedNCT01747239Phase 2
- Phase I/II Cabazitaxel for Recurrent Malignant GliomaWithdrawnNCT01740570Phase 1/2
- Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With TaxanesCompletedNCT01693549Phase 2
- Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With CabazitaxelCompletedNCT01668459Phase 2/3
- Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate CancerCompletedNCT01649635Phase 4
- A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and TaxanesCompletedNCT01620242Phase 2
- A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)CompletedNCT01600339Phase 2
- Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate CancerCompletedNCT01594918Phase 1
- Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate CancerCompletedNCT01576029Phase 2
- Second-line Chemotherapy in Castration Resistant Prostate CancerCompletedNCT01558219Phase 2
- Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01528163Phase 2
- Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal ImpairmentCompletedNCT01527929Phase 1
- Study of Weekly Cabazitaxel for Advanced Prostate CancerCompletedNCT01518283Phase 2
- Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior ChemotherapyCompletedNCT01497964Phase 1/2
- Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelTerminatedNCT01469338Phase 2
- Cabazitaxel With Radiation and Hormone Therapy for Prostate CancerCompletedNCT01420250Phase 1
- Cabazitaxel - PF Induction ChemotherapyCompletedNCT01379339Phase 1
- Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate CancerCompletedNCT01324583Phase 1
- Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing RegimenCompletedNCT01254279Phase 3
- Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentCompletedNCT01140607Phase 1
- Effect of Cabazitaxel on the QTc Interval in Cancer PatientsCompletedNCT01087021Phase 1
- A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid CancerCompletedNCT00925743Phase 1